Dolca Thomas - 26 May 2023 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 May 2023
Net transactions value
$0
Form type
4
Filing time
31 May 2023, 19:21:30 UTC
Previous filing
06 Sep 2022
Next filing
03 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDNY Common Stock Options Exercise +3,300 +33% 13,300 26 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Restricted Stock Units Options Exercise $0 -3,300 -100% $0.000000* 0 26 May 2023 Common Stock 3,300 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 Each RSU represents a contingent right to receive one share of Issuer's common stock.
F3 100% of the RSUs vested on May 26, 2023, subject to the Reporting Persons continued service to the Issuer on the vesting date.